Point-of-care Cholesterol Monitoring Devices
Market
Point-of-care Cholesterol Monitoring Devices Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Point-of-care Cholesterol Monitoring Devices Market Size and Growth
The Point-of-care Cholesterol Monitoring Devices market is experiencing significant growth due to rising cardiovascular diseases worldwide. The market size is estimated to be valued at $XXX million, with a projected CAGR of XX% from 2021 to 2026. Key players are focusing on product innovation and strategic partnerships to gain a competitive edge. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Roche
◍ Abbott
◍ ACON Laboratories
◍ Sinocare
◍ DiaSys Diagnostic Systems
◍ Abaxis
◍ SD Biosensor
◍ Bioptik
◍ Osang Healthcare
◍ Fitech
◍ Prima Lab SA
◍ Chematics
◍ AccuTech
Competitive Landscape: Roche and Abbott lead the market, followed by ACON Laboratories, Sinocare, DiaSys Diagnostic Systems, Abaxis, SD Biosensor, Bioptik, Osang Healthcare, Fitech, Prima Lab SA, Chematics, and AccuTech. These companies provide innovative Point-ofcare Cholesterol Monitoring Devices to drive market growth.
Overview of Companies:
- Roche: Offers the Accutrend Plus system.
- Abbott: Provides the i-STAT device.
- ACON Laboratories: Offers the Mission Cholesterol Meter.
- Sinocare: Provides the Safe AQ Smart Cholesterol Meter.
- DiaSys Diagnostic Systems: Offers the QDx Cholesterol Meter.
Sales Revenue Figures:
- Roche: $61.5 billion in 2020.
- Abbott: $34.6 billion in 2020. Request Sample Report
Market Segmentation
By Application
Hospital
Home Care Settings
Diagnostic Centers & Laboratory
Others
Request Sample Report
By Product
Instruments
Testing Kits
Market Growth
Request Sample Report
$ X Billion USD
